Company Overview
- Headquarters
- 40 Bear Hill Rd., Waltham MA
- Website
- minervabio.com
- dt****@minervabio.com
- Phone
- (781) 487-0200
- Employees
- 21
- Founded in
- 1999
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 54 CompaniesNAICS Code 54171 CompaniesNAICS Code 541 CompaniesNAICS Code 5417 CompaniesNAICS Code 541714 Companies
- SIC Code
-
SIC Code 873 CompaniesSIC Code 87 Companies
Financials & Stats
Revenue
$4B
Who is Minerva Biotechnologies Corporation
Minerva Biotechnologies Corporation is a clinical stage biopharmaceutical company headquartered in Waltham, Massachusetts. The company employs 21 people and generates $4 million in annual revenue. Minerva Biotechnologies specializes in developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine. Their primary focus is on developing CAR T therapies, with huMNC2-CAR44, targeting the MUC1* growth factor receptor, currently undergoing a first-in-human trial for metastatic breast cancers. Minerva is expanding this trial to include a second CAR-T product designed to enhance persistence. Beyond CAR-T therapies, Minerva's pipeline encompasses next-generation CAR-T products, a monoclonal antibody therapeutic, and a small molecule therapeutic, all aimed at treating cancer metastasis. For inquiries, please visit Minerva Biotechnologies' website at minervabio.com.
Minerva Biotechnologies Corporation Industry Tags
Minerva Biotechnologies Corporation Tech Stack
Companies Similar to Minerva Biotechnologies Corporation
Analyze industry trends and opportunities by examining competitors and companies comparable to Minerva Biotechnologies Corporation, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 4M | 5 | Scottsdale, AZ | ||
| 4M | 17 | Lawrenceville, GA | 2014 | |
| 4M | 8 | 2016 | ||
| 4M | 82 | 2016 | ||
| 4M | 11 | Las Vegas, NV | 2019 |